QRxPharma defendants can access class members’ broker details
Class Actions September 13, 2018 11:49 pm By Miklos Bolza | Sydney

The defendants in a shareholder class action over QRxPharma’s alleged failure to disclose problems with regulatory approval for its painkiller Moxduo have won access to […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.